Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development.

Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development.
复制标题

DOI:
10.3390/molecules27196430
复制
发表时间:
2022-09-29
期刊:
Molecules (Basel, Switzerland)
影响因子:
--
通讯作者:
Camarero JA
Camarero JA
中科院分区:
其他
文献类型:
--
作者:
Jacob B;Vogelaar A;Cadenas E;Camarero JA

文献摘要

参考文献

被引文献

相似文献

本文综述了环肽类化合物的性质及其开发新型肽类药物的潜力。蛋白质-蛋白质相互作用的选择性破坏仍然具有挑战性,因为相互作用表面相对较大且平坦。然而,具有细胞渗透性特性的高度受限的基于多肽的分子框架,如环肽支架,已经显示出针对这些生物分子相互作用的巨大前景。使用分子技术,如表位移植和采用环肽支架的分子进化,已被证明是非常有效的选择生物活性的环肽。
This review provides an overview of the properties of cyclotides and their potential for developing novel peptide-based therapeutics. The selective disruption of protein–protein interactions remains challenging, as the interacting surfaces are relatively large and flat. However, highly constrained polypeptide-based molecular frameworks with cell-permeability properties, such as the cyclotide scaffold, have shown great promise for targeting those biomolecular interactions. The use of molecular techniques, such as epitope grafting and molecular evolution employing the cyclotide scaffold, has shown to be highly effective for selecting bioactive cyclotides.
“剪接”药物发现。基于细胞的表达和筛选骨干环化多肽的遗传编码库。
DOI: 10.1016/j.addr.2009.07.003
发表时间: 2009-09-30
影响因子: 16.1
作者:
Sancheti, Harshkumar;Camarero, Julio A.
通讯作者: Camarero, Julio A.
DOI: 10.3390/molecules21020152
发表时间: 2016-01-26
期刊: Molecules (Basel, Switzerland)
影响因子: --
作者:
Aboye T;Meeks CJ;Majumder S;Shekhtman A;Rodgers K;Camarero JA
通讯作者: Camarero JA
DOI: 10.1016/j.chembiol.2015.04.010
发表时间: 2015-05-21
影响因子: --
作者:
Bernath-Levin, Kalia;Nelson, Clark;Mylne, Joshua S.
通讯作者: Mylne, Joshua S.
DOI: 10.1016/j.bmcl.2017.10.051
发表时间: 2017-12-01
影响因子: 2.7
作者:
Camarero JA
通讯作者: Camarero JA
DOI: 10.1021/bi049711q
发表时间: 2004-05-25
期刊: BIOCHEMISTRY
影响因子: 2.9
作者:
Colgrave, ML;Craik, DJ
通讯作者: Craik, DJ